Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,121 public trials 145 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Recruiting

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

NCT07354074

Conditions
Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +23 more
Locations
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Columbia University Medical Center New York Presbyterian New York, United States
  • Seattle Childrens Hospital Seattle, Washington, United States
  • Novartis Investigative Site Brisbane, Queensland, Australia
View all 30 locations
View Trial Details
Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +137 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 745 locations
View Trial Details
Recruiting

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

NCT05322850

Conditions
Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Acute Undifferentiated Leukemia, +29 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
View Trial Details
Recruiting

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

NCT04838041

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myelogenous Leukemia, +12 more
Locations
  • The Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Huntsman Cancer Institute Salt Lake City, Utah, United States
  • Froedtert Hospital & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Recruiting

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

NCT07623161

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +4 more
Locations
  • Los Angeles Cancer Network Glendale, California, United States
  • Cancer and Blood Specialty Clinic Whittier, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Advanced Research, LLC Coral Springs, Florida, United States
View all 195 locations
View Trial Details

Related conditions